scispace - formally typeset
A

Aimé G. Fankam

Researcher at University of Dschang

Publications -  27
Citations -  1230

Aimé G. Fankam is an academic researcher from University of Dschang. The author has contributed to research in topics: Minimum inhibitory concentration & Efflux. The author has an hindex of 15, co-authored 24 publications receiving 933 citations.

Papers
More filters
Journal ArticleDOI

Antibacterial activities of selected edible plants extracts against multidrug-resistant Gram-negative bacteria

TL;DR: The results of the present work provide useful baseline information for the potential use of the studied edible plants in the fight against both sensitive and MDR phenotypes.
Journal ArticleDOI

Antibacterial activities of selected Cameroonian spices and their synergistic effects with antibiotics against multidrug-resistant phenotypes

TL;DR: The results of the antibacterial assays indicated that all tested extracts exert antibacterial activities, with the minimum inhibitory concentration values varying from 32 to 1024 μg/ml.
Journal ArticleDOI

Cytotoxicity of some Cameroonian spices and selected medicinal plant extracts.

TL;DR: The overall results of the present study provide supportive data on the use of some Cameroonian plants for cancer treatment and indicate that the anti-angiogenic properties of the most active extracts were able to inhibit angiogenesis by more than 50% in quail embryo.
Journal ArticleDOI

Antibacterial activities of Beilschmiedia obscura and six other Cameroonian medicinal plants against multi-drug resistant Gram-negative phenotypes

TL;DR: Phenylalanine arginine β-naphthylamide (PAβN) significantly modulated the activities of extracts from the leaves and fruits of Pachypodanthium staudtii and Beilschmiedia obscura respectively, by increasing their inhibitory activity against Klebsiella pneumoniae KP55 strain at least four fold.
Journal ArticleDOI

Cytotoxicity and Modes of Action of the Methanol Extracts of Six Cameroonian Medicinal Plants against Multidrug-Resistant Tumor Cells

TL;DR: The three active plants, Gladiolus quartinianus, Vepris soyauxii, and Anonidium mannii, may be a source for the development of new anticancer drugs.